Search by Character/Letter String, CAS, JECFA, FEMA, FL-No or Industry Name
Download GRL
Industry Name
CAS
JECFAunfold_more
FEMAunfold_more
FL-Noexpand_more
Glutamyl-valyl-glycine 38837-70-6 2123 4709 17.038
L-Methionylglycine 14486-03-4 2122 4692 17.037
S-Allyl-L-cysteine 21593-77-1 1710 4322 17.036
4-Aminobutyric acid 56-12-2 1771 4288 17.035
Glycine 56-40-6 1421 3287 17.034
l-Cysteine 52-90-4 1419 3263 17.033
l-Cysteine hydrochloride 52-89-1 3263 17.032
l-Lysine monochlorhydrate 657-27-2 17.031
l-Valine 72-18-4 1426 3444 17.028
l-Methionine 63-68-3 1424 3301 17.027
L-Lysine 56-87-1 1439 3847 17.026
DL-Alanine 302-72-7; 338-69-2 1437 3818 17.024
Valine 516-06-3; 640-68-6 1426 3444 17.023
L-Thyrosine 60-18-4 1434 3736 17.022
Threonine 80-68-2; 632-20-2 2119 4710 17.021
Serine 302-84-1 17.020
Proline 147-85-3; 609-36-9; 344-25-2 1425 3319 17.019
L-Phenylalanine 63-91-2 1428 3585 17.018
DL-Phenylalanine 150-30-1; 673-06-3 1432 3726 17.017
DL-(3-Amino-3-carboxypropyl)dimethylsufonium chloride 3493-12-7; 1115-84-0 1427 3445 17.015
DL-Methionine 59-51-8; 348-67-4 1424 3301 17.014
DL-Lysine 70-54-2; 923-27-3 1439 3847 17.013
Leucine 61-90-5; 328-39-2; 328-38-1 1423 3297 17.012
dl-Isoleucine 443-79-8 1422 3295 17.010
L-Histidine 71-00-1 1431 3694 17.008
L-Glutamine 56-85-9 1430 3684 17.007
Cystine 56-89-3 17.006
L-Aspartic acid 56-84-8 1429 3656 17.005
L-Arginine 74-79-3 1438 3819 17.003
L-Alanine 56-41-7 1437 3818 17.002
Alanine 107-95-9 1418 3252 17.001
2-(4-Methylphenoxy)-N-(1H-pyrazol-3-yl)-N-(thiophen-2-ylmethyl)acetamide 1374760-95-8 2237 4809 16.133
4-Amino-5-(3-(isopropylamino)-2,2-dimethyl-3-oxopropoxy)-2-methylquinoline-3-carboxylic acid (and its hemisulfate monohydrate salt) 1359963-68-0; 1460210-04-1 2204 4774 16.130
3-(1-((3,5-Dimethylisoxazol-4-yl)methyl)-1H-pyrazol-4-yl)-1-(3-hydroxybenzyl)-imidazolidine-2,4-dione 1119831-25-2 2161 4725 16.127
3[(4-Amino-2,2-dioxido-1H-2,1,3-benzothiadiazin-5-yl)oxy]-2,2-dimethyl-N-propylpropanamide 1093200-92-0 2082 4701 16.126
(2S,5R)-N-[4-(2-Amino-2-oxoethyl)phenyl]-5-methyl-2-(propan-2-yl)cyclohexanecarboxamide 1119711-29-3 2078 4684 16.125
(1R,2S,5R)-N-(4-Methoxyphenyl)-5-methyl-2-(1-methylethyl)cyclohexanecarboxamide 68489-09-8 2079 4681 16.123
(+/-) 4-Methyl-2-propyl-1,3-oxathiane 1064678-08-5 2089 4677 16.122
(2E,6E/Z,8E)-N-(2-Methylpropyl)-2,6,8-decatrienamide 25394-57-4; 504-48-3 2077 4668 16.121
N-(2-Methylcyclohexyl)-2,3,4,5,6-pentafluorobenzamide 1003050-32-5 2081 4678 16.119
N-(2-(Pyridin-2-yl)ethyl)-3-p-menthanecarboxamide 847565-09-7 2008 4549 16.118
N-p-Benzene acetonitrile-menthane-carboxamide 852379-28-3 2009 4496 16.117
4-Amino-5,6-dimethylthieno[2,3-d]pyrimidin-2(1H)-one (hydrochloride) 121746-18-7; 1033366-59-4 2117 4669 16.116
Cyclopropanecarboxylic acid (2-isopropyl-5-methyl-cyclohexyl)-amide 958660-02-1; 958660-04-3 2006 4558 16.115
(+/-)-cis- and trans-2-Pentyl-4-propyl-1,3-oxathiane 59323-81-8 1943 4499 16.114
Rebaudioside A 58543-16-1 4601 16.113
Trilobatin 4192-90-9 2171 4674 16.112
N-[(Ethoxycarbonyl)methyl)-p-menthane-3-carboxamide 68489-14-5 1776 4309 16.111
Naringin dihydrochalcone 18916-17-1 2208 4495 16.110
3-(4-Hydroxy-phenyl)-1-(2,4,6-trihydroxy-phenyl)-propan-1-one 60-82-2 2022 4390 16.109
(+/-)-N-Lactoyl tyramine 781674-18-8 2007 4550 16.107
N-Gluconyl ethanolamine phosphate 791807-20-0 1773 4255 16.105
N-Lactoyl ethanolamine phosphate 782498-03-7 1775 4257 16.104
N-Lactoyl ethanolamine 5422-34-4 1774 4256 16.103
N-(2-Hydroxyethyl)galactonamide 686298-93-1 1772 4254 16.102
N1-(2-Methoxy-4-methylbenzyl)-N2-(2-(pyridin-2-yl)ethyl)oxalamide 745047-97-6 1770 4231 16.101
N1-(2-Methoxy-4-methylbenzyl)-N2-(2-(5-methylpyridin-2-yl)ethyl)oxalamide 745047-94-3 1769 4234 16.100
N1-(2,4-Dimethoxybenzyl)-N2-(2-(pyridin-2-yl)ethyl)oxalamide 745047-53-4 1768 4233 16.099
N-(Heptan-4-yl)benzo[d][1,3]dioxole-5-carboxamide 745047-51-2 1767 4232 16.098
5,7-dihydroxy-2-(3-hydroxy-4-methoxy-phenyl)-chroman-4-one 69097-99-0; 520-33-2 2024 4313 16.097
Ferrous lactate 5905-52-2; 85993-25-5 4699 16.096
N-3,7-Dimethyl-2,6-octadienyl cyclopropylcarboxamide 744251-93-2 1779 4267 16.095
(+/-) N,N-Dimethyl menthyl succinamide 544714-08-1 1602 4230 16.092
N-Isobutyl (E,E)-2,4-decadienamide 18836-52-7 1598 4148 16.091
N-[2-(3,4-Dimethoxyphenyl)ethyl]-3,4-diemethoxycinnamic acid amide 69444-90-2 1777 4310 16.090
Ferric ammonium citrate 1185-57-5 16.089
l-Menthyl methyl ether 1565-76-0 1415 4054 16.088
N-Benzoylanthranilic acid 579-93-1 1552 4078 16.087
(-)-Homoeriodictyol sodium salt 462631-45-4 2256 4228 16.083
Sucrose octaacetate 126-14-7 3038 16.081
Tannic acid 1401-55-4; 72401-53-7 3042 16.080
Ethyl vanillin beta-D-glucopyranoside 122397-96-0 0892 3801 16.075
Sodium diacetate 126-96-5 3900 16.073
trans-2-methyl-4-propyl-1,3-oxathiane 59324-17-3 16.062
Neohesperidin dihydrochalcone 20702-77-6 3811 16.061
Glycyrrhizic acid, ammoniated 53956-04-0 2528 16.060
Ammonium hydrogen sulphide 12124-99-1 2053 16.059
Naringin 10236-47-2 16.058
Taurine 107-35-7 1435 3813 16.056
Sclareolide 564-20-5 1165 3794 16.055
2-Isopropyl-N,2,3-trimethylbutyramide 51115-67-4 1595 3804 16.053
1,6-Hexalactam 105-60-2 1594 4235 16.052
Ammonium chloride 12125-02-9 4494 16.048
beta-Caryophyllene oxide 1139-30-6 1575 4085 16.043
Sodium 2-(4-methoxyphenoxy)propanoate 150436-68-3 1029 3773 16.041
Ethyl methyl-p-tolylglycidate 74367-97-8 1578 3757 16.040
Potassium 2-(1'-ethoxy)ethoxypropanoate 100743-68-8 0933 3752 16.039
Theobromine 83-67-0 3591 16.032
2-Methyl-4-propyl-1,3-oxathiane 67715-80-4 0464 3578 16.030
Thiamine hydrochloride 67-03-8 1030 3322 16.027
Ethyl 3-phenyl-2,3-epoxypropionate 121-39-1 1576 2454 16.018
Caffeine 58-08-2 2224 16.016
Ethyl methylphenylglycidate 77-83-8 1577 2444 16.015
N-Ethyl 2-isopropyl-5-methylcyclohexanecarboxamide 39711-79-0 1601 3455 16.013
Glycyrrhizic acid 1405-86-3 16.012
Ammonia 7664-41-7 4494 16.009
Hydrogen sulfide 7783-06-4 3779 16.007
Nonanoyl 4-hydroxy-3-methoxybenzylamide 2444-46-4 1599 2787 16.006
diammonium sulfide 12135-76-1 2053 16.002
3-Ammonium isovalerate 7563-33-9 1203 2054 16.001
Agreement Disclaimer
The IOFI secretariat has prepared the GRL with the intention to be complete and up-to-date with the available safety information. IOFI cannot be held liable for errors or omissions in this document. Neither IOFI or any individual member or officer can be held liable for any loss or damage as a result of relying on the IOFI GRL.

Please report any potential errors and forward suggested corrections to the IOFI secretariat.

The Terms and Conditions of Use file_download

I understand and accept the Terms and Conditions of Use.